tiprankstipranks
Anatara Secures European Patent for GaRP Product
Company Announcements

Anatara Secures European Patent for GaRP Product

Anatara Lifesciences Ltd (AU:ANR) has released an update.

Don't Miss our Black Friday Offers:

Anatara Lifesciences Ltd has announced the European Patent Office’s grant of a patent for its GaRP product, aimed at improving gastrointestinal health. This patent solidifies the company’s intellectual property position in Europe, especially if ongoing trials for GaRP, a complementary medicine for chronic gastrointestinal conditions like IBS and IBD, prove successful. The granted patent, which builds on Australian priority filings, ensures protection until 2039.

For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App